Speaker Faculty
Plenary Keynotes:
Peter G. Schultz, Ph.D., The Scripps Research Institute and Director
Gregory L. Verdine, Ph.D., Harvard University
Distinguished Faculty:
Andrew Andrews, Fox Chase Cancer Center
Paola Arimondo, CNRS
C. Glenn Begley, TetraLogic Pharmaceuticals
Ashok Bhandari, Protagonist Therapeutics
Jark Böttcher, Boehringer Ingelheim RCV GmbH & Co KG
Michael Bradshaw, Principia Biopharma
Stacie Bulfer, University of California, San Francisco
Chris Burns, Walter and Eliza Hall Institute
Eric Campeau, Zenith Epigenetics
Philip Chamberlain, Celgene
Huifen Chen, Genentech
Alessio Ciulli, University of Dundee
Derek Cole, Takeda
Philip Collier, Vertex Pharmaceuticals
John Comer, Sirius Analytical
Stuart Conway, University of Oxford
Chitta Das, Purdue University
Tom Davies, Astex Pharmaceuticals
Ben Davis, Vernalis Research
Iwan de Esch, VU University & Griffin Discoveries BV
Jerome Deval, Alios BioPharma (J&J)
Paola Di Lello, Genentech
George Doherty, Abbvie
Alexander Dömling, University of Groningen
Donald Durden, SignalRx Pharmaceuticals
Matthew Eddy, University of Southern California
William Elmquist, University of Minnesota
Istvan Enyedy, Biogen
Daniel Erlanson, Carmot Therapeutics
Evelyne Fontaine, Sanofi
Robert Foster, Ciclofilin Pharmaceuticals
Robert Fraczkiewicz, Simulations Plus
Matthias Frech, EMD Serono
Matthew Fuchter, Imperial College London
Robert Gish, Robert G. Gish Consultants
Eric Goedken, AbbVie
Val Goodfellow, Califia Bio
Mary Harner, Bristol Myers Squibb
Michael Hewitt, Constellation Pharmaceuticals
Robert Hughes, Boehringer-Ingelheim
Alexander (Sandy) Hurd, Lycera
Radhakrishnan Iyer, Spring Bank Pharmaceuticals
Matthew Jacobson, University of California, San Francisco
Yutao Jiang, Genentech
Ramon Jimenez-Moreno, ASINEX
Ted Johnson, Pfizer Oncology
Tim Kaminski, AstraZeneca
Jan Kihlberg Uppsala University
Thomas Kodadek, The Scripps Research Institute, Scripps Florida
Roman Kombarov, ASINEX
Alexandr Kornev, University of California, San Diego
Irina Kufareva, Univeristy of California, San Diego
Ravi Kurumbail, Pfizer
Shenping Liu, Pfizer Global R&D
Paul Lockman, West Virginia University Health Science Center
Scott Lokey, University of California, Santa Cruz
Kevin Lumb, Janssen R&D
Doug Marcotte, Biogen
Jose Marquez, (EMBL) Grenoble Outstation
Eric Marsault, University of Sherbrooke
Elisabeth Martinez, University Texas Southwestern Medical Center
Andreas Marzinzik, Novartis Institute BioMedical Research
Alan Mathiowetz, Pfizer Worldwide Medicinal Chemistry
Larry Mattheakis, Protagonist Therapeutics
Matthew McClure, Alios BioPharma (J&J)
Essam Metwally, Chemical Computing Group
Lorna Mitchell, Epizyme
Christian Montalbetti, Inventiva
Gerhard Mueller, MercaChem BV
Songqing Na, Eli Lilly and Company
James Naismith, St. Andrews University
Radek Nowak, University of Oxford
Daniel Obrecht, Polyphor
Feroz Papa, University of California, San Francisco
William Pardridge, ArmaGen
Jighar Patel, Roche NimbleGen
Samarjit Patnaik, NIH
Dehua Pei, The Ohio State University
Juan Jesus Perez, Technical University of Catalonia
Kevin Peters, Aerpio Therapeutics
Mark Peterson, Cyclenium Pharma
Christopher Phelps, GSK
Jason Pickens, Takeda
William Pomerantz, University of Minnesota
John Quinn, Genentech
Nir Qvit, Stanford University School of Medicine
Shahrooz Rabizadeh, NantBioScience
Murali Ramachandra, Aurigene Discovery Technology
Adam Renslo, University of California, San Francisco
Michael Reutershan, Merck Research Labs
Martin Scanlon, Monash Institute for Pharmaceutical Sciences
Joerg Scheuermann, ETH Zurich
Mark Schnute, Pfizer Global R&D
Eric Schwartz, Celgene Avilomics Research
Phillip Schwartz, Takeda California
Qiang Shi, National Center for Toxicology Research, FDA
Laura Silvian, Biogen
Dan Sindhikara, Schrödinger
Dhanalakshmi Sivanandhan, Jubilant Biosys
Chris Smith, COI Pharmaceuticals
Michael Sofia, Arbutus Biopharma
Oliver Sperandio, Inserm
Terry Stouch, Science for Solutions
Yongchao Su, Merck Research Laboratories
John Sullivan-Bólyai, ContraVir Pharmaceuticals
Takayoshi Suzuki, Kyoto Prefectural University of Medicine
Ramzi Sweis, AbbVie
Seng-Lai “Thomas” Tan, FORMA Therapeutics
Leticia Toledo-Sherman, CHDI Foundation
Maricel Torrent, AbbVie
Andrew Vaillant, Replicor
Michael Vazquez, Pfizer
Sandrine Vendeville, Janssen Infectious Diseases (J&J)
Hari Venkatesan, Janssen R&D
Florence Wagner, The Broad Institute
Jakob Wallner, University of Vienna
Xiaolun Wang, Takeda San Diego
Patrick Woster, Medical University of South Carolina
Huixian Wu, The Broad Institute
Ryan Wurz, Amgen
David Wustrow, Cleave Biosciences
Wendy Young, Genentech
Christoph Zapf, Pfizer Research Labs
Rumin Zhang, Merck Research Laboratories
Xiaolin Zhang, AstraZeneca